WHERE ARE YOU IN YOUR CLINICAL TRIAL?
By being a catalyst for planning success, assuring data integrity, avoiding recognizable pitfalls and staying on plan, new life-improving therapies have a greater chance of making through to market.
OFFERING POWERFUL INSIGHT INTO CLINICAL TRIAL DEVELOPMENT
Clinical Trial Software
Bioclinica’s investments in innovative digital technology, including artificial intelligence (AI) and cloud-based platforms, are changing the landscape of clinical trials and improving patients’ quality of life.
Bioclinica offers centralized medical imaging solutions coupled with deep scientific, regulatory, and medical expertise to adeptly support your clinical research across all major therapeutic areas including: oncology, neuroscience, musculoskeletal, hepatology (NAFLD/NASH), gastroenterology, cardiovascular and more.
Bioclinica supports your entire study cycle, from Phase I to Phase IV. We offer a range of services to help you effectively plan, implement, and report on the cardiovascular safety of your drug.
The Bioclinica Imaging Platform leverages our in-house medical expertise to increase accuracy, reduce costs, and model the complexity of your clinical trial protocols.
Bioclinica has extensive experience with medical imaging and diagnostic imaging modalities for clinical trials: CT, DXA, endoscopy, medical photography, MRI, molecular imaging, OCT, ultrasound, radiography.
Bioclinica’s Office-Smart CTMS solution provides the single, centralized truth across all clinical trial and logistical project information. The familiar Microsoft interface significantly increases user adoption, use-based pricing mitigates the risk of procurement and rapid deployment model provides a fully operational system in only a few weeks.
Bioclinica’s EDC family provides a range of services that enable you to eliminate obstacles, operate more efficiently and easily manage data for a single study or a global portfolio of clinical trials — all using a single, powerful platform that combines our deep EDC experience with impressive ease of use to put everything you need at your fingertips, on any device you have at hand.
Significantly reduce time, implementation effort and cost for even the most complex global trials using the industry’s only purpose-built, end-to-end, configurable RTSM solution – combining Bioclinica’s Interactive Response Technologies (IRT) and advanced Trial Supply Optimization (TSO) application.
Improve cash management and financial risk mitigation as well as site payment transparency, control, and accuracy, while reducing payment-related workload and costs, with Bioclinica’s Site & Patient Payments platform.
Maintain focus on outcomes and ensure compliance, accuracy, and transparency for event adjudication. Our Clinical Adjudication Solution combines project management and in-house clinical expertise centralized on a cloud-based platform.
Reduce compliance risk and protect patient privacy with SMART Submit. Our cloud-based solution de-identifies DICOM medical images for you to collect, store, and share with your sponsor or core labs.
Take your clinical trial to the next level with advanced AI technology that automatically redacts sensitive patient identifiers from videos, images, and PDFs.
Support future clinical trials or audits with secure, web-based storage that allows you to search, view, and share GDPR-compliant images for up to 25 years.
Ensure a trial’s quality and timeline are always at the forefront through a customized, streamlined, and transparent image viewing process on a cloud-based platform. Create custom workflows to boost your image review productivity and improve process efficiency.
Drug Safety Solutions provide the depth and breadth of Operational support with Physicians and Scientists. Our team includes more than 1,300 staff located in the EU, USA, Japan, China and India supporting over 35 long-term Clients.
ALL GOOD THERAPIES SHOULD MAKE IT TO MARKET
A company was facing significant challenges in a global clinical trial program with 30 studies for an uncommon indication. Not…
Featured Speaker: Kevin Bishop, VP, RTSM, BioclinicaDuration: 1 hour Although often not a component of the initial study plan, a contingency…
Non-alcoholic fatty liver disease (NAFLD), and its progression to non-alcoholic steatohepatitis (NASH), is estimated to become the most common chronic…
Children are a protected segment of society and pediatric clinical trials are critical to the development of new treatments for…